Supplier News

LabConnect built a biorepository facility in Tennessee.

Novasep is building a new synthesis laboratory and adding capacity for kilogram-scale batches of synthetic molecules that are needed for biological testing and preclinical trials, at its Pennsylvania, US facility.

The partnership will focus on the identification and analysis of host-cell proteins in biologics.

The new website, dubbed “Integrated Solutions”, helps clients implement single-use solutions and hybrid biomanufacturing processes.

GS1 US announces the expansion of its advisory services program to address industry needs.

Austrianova completes facility for GMP cell banking and fill/finish services for cell therapy products.

SGS Life Sciences expands chemistry and microbiology testing services after acquisition of Quality Compliance Laboratories.

FDA grants AbbVie breakthrough therapy designation for venetoclax in combination with rituximab for the treatment of relapsed/refractory chronic lymphocytic leukemia.

The collaboration will focus on development of novel molecules using SMARTag technology to couple different therapeutic modalities.

Charles River Laboratories entered into a definitive agreement to acquire WIL Research.

The company’s new version of its glycan analysis tool will help investigators determine the relative abundance of individual N-glycan structures in small biopharmaceutical samples.

AMRI adds analytical capabilities to its outsourcing services offerings with the acquisition of Whitehouse Labs.

Grand River Aseptic Manufacturing expands disposable technology capabilities at aseptic facility.

Vetter receives AEO-F certificate from the European Union for global movement of goods.

The portal is an interactive tool that pulls together the innovation landscape, company base, and manufacturing sites for the entire medicines sector in the UK.

The University of Sheffield has appointed Cobra Biologics to advance novel fusion protein technology into Phase 1 clinical trials.

Expansions at Catalent’s Kansas City, MO, and Madison, WI facilities made in response to industry demand.

Baxter expands capacity for lyophilized cytotoxic oncology therapies at its fill/finish facility in Halle, Germany.

Thermo Fisher Scientific announced the opening of their new GMP clinical services facility in Singapore.

Charles River Laboratories announces the acquisition of Oncotest GmbH.

Baxter expands capacity for lyophilized cytotoxic oncology therapies at its fill/finish facility in Halle, Germany.

Merck KGaA announces the completion of the acquisition of Sigma-Aldrich, a St. Louis-based life-sciences and technology company.

BioOutsource releases informational video detailing issues associated with ADCC assays and how to effectively analyze them.

The UK’s National Biologics Manufacturing Centre will use Novasep’s BioSC Lab for protein purification.

GE Healthcare's KUBio prebuilt modules were shipped from Germany to JHL Biotech in Wuhan, China.

The company said its DevClin business will continue to be an integral part of its long-term biologics business growth strategy.

The new IVIG products boast improvements in purity, safety, and yield.

The testing laboratory will add capacity to strengthen its early-stage drug research capabilities for its small and large biotech clients.

According to Bio-Rad executives, the company’s adoption of its ERP system has created a backlog of projects.